Nutex Health Inc. (NUTX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated April 30, 2026, announces the financial and operating results for Nutex Health Inc. for the first quarter ended March 31, 2026. The Company is incorporated in Delaware and trades on the NASDAQ Stock Market under the symbol NUTX.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to Exhibit 99.1 for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The report explicitly states that the information in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the specific Q1 2026 financial results (revenue, net income, cash flow) in the attached press release (Exhibit 99.1).
- Confirm any year-over-year or quarter-over-quarter changes in operating metrics not detailed in this summary.
- Review the full text of the press release for any forward-looking statements or updated guidance.
- Note that the financial data in this 8-K is not deemed "filed" under Section 18 of the Exchange Act.